Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial.

At the same time, these results document an expected finding: the relatively small improvement in nominal survival with TAVI—which did not reach statistical significance in the trial—can lead to a not insignificant proportion of simulations where SAVR is found to be associated with a higher QALY gain than TAVI.

also in 111,027 other papers